Jane was appointed as a Staff Specialist to Westmead Hospital in 1998 and is a Clinical Associate Professor, Sydney University Medical School. She completed her PhD in 1999 in mitochondrial DNA mutations and diabetes. She developed a clinical model to improve the process of transition for young people with diabetes and a significant part of her clinical research aims to improve health outcomes for young people with chronic disease. She has been actively involved in the National islet Transplant Program and promoting its benefits for type I diabetes complicated by severe hypoglycemia and contributed to the application for NFC status for islet transplantation, achieved in 2012. She has been involved at a National level developing guidelines for type I diabetes, Cystic Fibrosis related diabetes and Insulin Pump Therapy working with experts across Australia. She has developed teaching tools to assist Endocrinologists in management of insulin pump therapy. She has extensive experience in insulin pump therapy and use of continuous glucose monitoring, and outside of islet cell transplantation, sees this as the main platform for prevention of hypoglycemia for patients with type I diabetes. She has over 30 research publications.
Jane was appointed to the ADS executive in 2014.
Abstracts this author is presenting: